Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38 mitogen-activated protein kinases (p38 MAPKs) are a class of serine/threonine protein kinases that play a central role in cellular responses to stress and inflammation. They are activated by various extracellular stimuli and regulate processes such as cell differentiation, apoptosis, autophagy, and the production of inflammatory mediators. There are four main isoforms of p38 MAPK in mammals: p38α, p38β, p38γ, and p38δ. Dysregulation or persistent activation/inhibition is implicated in several diseases including cancer, neurodegenerative disorders, inflammatory diseases, and cardiovascular conditions. Numerous small-molecule inhibitors targeting different subtypes have been developed.
Small molecule inhibitors bind to the ATP-binding pocket of p38 isoforms, preventing phosphorylation of downstream targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P38 mitogen‐activated protein kinase (None).